Insider Trading & Ownership - BIOS Incysus Co-Invest I LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BIOS Incysus Co-Invest I LP
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-12-12
Purchase		 2022-12-13
07:00 am		 IN8BIO INC. INAB Fletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner		 75,001 $2.4788 $185,912 4,270,424
(Indirect)		 View
2022-09-28
Purchase		 2022-09-29
06:14 am		 IN8BIO INC. INAB Fletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
BIOS Capital Management LP
BIOS Advisors GP LLC
Director
10% Owner		 25,000 $2.0214 $50,535 4,261,689
(Indirect)		 View
2022-08-26
Purchase		 2022-08-30
1:16 pm		 IN8BIO INC. INAB Fletcher Aaron G.L.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		 51,214 $2.0178 $103,340 4,258,776
(Indirect)		 View
2022-08-26
Purchase		 2022-08-30
08:10 am		 IN8BIO INC. INAB Kreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		 51,214 $2.0178 $103,340 4,258,776
(Indirect)		 View
2022-08-17
Purchase		 2022-08-18
8:00 pm		 IN8BIO INC. INAB Kreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		 50,000 $1.93 $96,500 4,252,810
(Indirect)		 View
2022-08-16
Purchase		 2022-08-17
10:27 am		 IN8BIO INC. INAB Kreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund III QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
Director
10% Owner		 1,773,684 $1.9 $3,370,000 4,348,150
(Indirect)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-10-04
Option Award		 2024-10-11
6:12 pm		 2023-12-13
2025-10-04		 IN8BIO INC. INAB Fletcher Aaron G.L.
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Incysus Co-Invest I LP
Bios Clinical Opportunity Fund LP
Bios Equity COF LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner		 574,241 $0 11,862,579
(Indirect)		 View
2021-08-03
Conversion		 2021-08-03
4:57 pm		 N/A
N/A		 IN8BIO INC. INAB Kreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner		 12,649,578 $0 359,374
(Indirect)		 View

Ownership		 2021-07-29
9:36 pm		 N/A
N/A		 IN8BIO INC. INAB Kreis Leslie W.
BIOS Fund II NT LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Incysus Co-Invest I LP
Bios Equity Partners II LP
BIOS Equity Partners III LP
Cavu Management LP
Cavu Advisors LLC
10% Owner		 0 $0 6,625,102
(Indirect)		 View